Abstract | Ever since initial suggestions that instability at common fragile sites (CFSs) could be responsible for chromosome rearrangements in cancers, CFSs and associated genes have been the subject of numerous studies, leading to questions and controversies about their role and importance in cancer. It is now clear that CFSs are not frequently involved in translocations or other cancer-associated recurrent gross chromosome rearrangements. However, recent studies have provided new insights into the mechanisms of CFS instability, their effect on genome instability, and their role in generating focal copy number alterations that affect the genomic landscape of many cancers. NATURE REVIEWS | CANCER VOLUME 17 | AUGUST 2017 | 489 PERSPECTIVES © 2 0 1 7 M a c m i l l a n P u b l i s h e r s L i m i t e d , p a r t o f S p r i n g e r N a t u r e . A l l r i g h t s r e s e
Common fragile sites (CFSs) were first described in 1984 as sites on human metaphase chromosomes that are particularly prone to forming cytogenetically defined chromosomal gaps or breaks following the partial inhibition of DNA synthesis 1 (FIG. 1) . The same CFSs were seen in all individuals studied and thus were thought to represent a conserved component of chromosome structure. Interest in CFSs rapidly increased for two reasons. First, the agents and conditions that lead to CFS formation (that is, CFS expression) allowed the identification of factors that are involved in the cellular response to perturbed replication known as 'replication stress' . Second, and more prominently, the association of CFSs with recurrent chromosome rearrangements in cancers, including those involving oncogenes, suggested that CFSs could be responsible for these events and could be drivers of tumorigenesis or tumour progression [2] [3] [4] [5] [6] . Notably, these associations were made without the benefit of the human genome sequence or precise mapping of either the chromosome rearrangements or the CFSs. Most studies used classical cytogenetic techniques to identify and define CFSs but, as discussed below, advances in genomic technologies and new experimental findings have enabled the refinement of frequently seen CNVs in cancer cells. This Opinion article focuses on recent findings on the mechanisms of CFS instability and their biological consequences in cancer that support this view.
Basic properties of CFSs
CFSs are specific chromosomal loci that are prone to forming visible gaps and breaks on metaphase chromosomes under conditions that perturb normal DNA synthesis, thus causing replication stress 1 . Most commonly, cells are treated with low concentrations of the DNA polymerase inhibitor aphidicolin (APH), which slows but does not completely block DNA synthesis. Folate deficiency 1 and low doses of the ribonucleotide reductase inhibitor hydroxyurea 11 , which reduces cellular dNTP pools, have lesser but similar effects. CFS gaps and breaks were initially defined and mapped at low resolution on metaphase chromosomes using accepted cytogenetic definitions of chromosome gaps and breaks 12 without knowledge of the specific underlying DNA integrity or chromatin structure, including the presence or absence of DNA double-strand breaks (DSBs) 1 . The original report 1 , which nominated a CFS if it was expressed in at least 6 of 50 cells, identified 17 CFS loci in cultured human lymphocytes, with the most frequent being 3p14 (FRA3B), 16q23 (FRA16D) and 6q26 (FRA6E). Subsequent reports defined CFSs using similar criteria and led to 75 APH-type CFSs being listed in the US National Center for Biotechnology Information (NCBI) Gene Database. However, there was no consensus about the statistical criteria needed to differentiate a 'true' CFS from a random or low-frequency APH-induced gap or break 13 . Furthermore, most of these CFSs were mapped only at the chromosome band level with a resolution of >1 Mb. Thus, although still a useful guide, the NCBI Gene Database CFS data are now mostly outdated based on our current ability to precisely localize CFSs in different cell types and to measure their relative instability at the genomic level. Nonetheless, it has been clear that, in all cell types, the majority of CFS breaks occur at approximately 10-20 of the most sensitive and unstable sites in APH-treated cells. For example, in lymphocytes, gaps and breaks at CFS locations and have greatly expanded this experimental paradigm. It is now apparent that, unlike the so-called early replicating fragile sites 7 , most CFSs are infrequently involved in translocations and other recurrent gross cancer chromosome rearrangements, and their locations do not coincide with oncogenes. Instead, genes underlying CFSs, such as fragile histidine triad (FHIT) and WW domain containing oxidoreductase (WWOX), were found to be sites of recurrent deletions in multiple tumour types, suggesting that they may function as tumour suppressor genes 8, 9 . The Cancer Genome Atlas (TCGA) and other studies have now revealed that de novo copy number variants (CNVs; de novo CNVs are also known as copy number alterations (CNAs)) arise at a high frequency in most tumour types and that CFS loci are highly prone to their occurrence 10 . Recent studies have greatly advanced our understanding of the mechanistic basis for CFS instability and the resulting genomic effects, which have broad implications for CNVs and other genomic rearrangements that arise in cancer and in normal cells. Our current view is that CFS gaps and breaks on metaphase chromosomes were only the first indicators of an unusually high instability of large, late-replicating, actively transcribed genes that also manifests as many of the most Fragile sites in cancer: more than meets the eye Thomas W. Glover [1] [2] [3] , Thomas E. Wilson 1, 2 and Martin F. Arlt 1 only 20 CFSs represent more than 80% of all cytogenetic lesions following low-dose APH treatment 1 . Experiments in cultured cells have also shown that, in addition to metaphase gaps and breaks, CFSs are hotspots for sister chromatid exchanges (SCEs) 14, 15 , can lead to translocations and deletion breakpoints in somatic cell hybrid systems 16, 17 and are preferred sites of integration for transfected plasmid DNA 18 . These and other properties of CFSs have been described in detail in a number of past reviews [19] [20] [21] .
CFSs are late replicating. Late replication has long been known to be a key factor in CFS instability. Using fluorescence in situ hybridization (FISH) probes in FRA3B, LeBeau et al. 22 demonstrated that sequences at FRA3B undergo DNA replication very late in the S phase of the cell cycle and that APH causes a further delay in replication, extended over hundreds of kilobases, identifying CFSs as large, regional genomic features. Importantly, FRA3B mapped within the large 1.5 Mb FHIT gene at 3p14.2 and FRA16D mapped within the 1.1 Mb WWOX gene at 16q23 (REFS 9, 26) . The association of CFSs with unusually large genes (the median human gene size is ~23 kb) was later extended to 13 other CFSs that were only recently characterized at the molecular level 19, 27, 28 . Reports of CFSs extending over several megabases may be influenced by two or more large CFS-associated genes mapping so close together as to be indistinguishable at the cytogenetic level, as was shown for CFSs in the AUTS2 and MAGI2 genes on chromosome 7 (REF. 29 ). Recent findings, discussed below, offer mechanistic explanations for this interesting association between large gene size and the occurrence of a CFS and suggest that most, if not all, large, actively transcribed, late-replicating genes have the potential to be CFSs.
CFSs show cell type specificity. An important factor in defining and studying CFSs is their cell type specificity. Most early CFS studies were carried out using cultured lymphocytes and lymphoblastoid cell lines. Fibroblast-specific fragile sites were noted in early studies by Murano et al. 30, 31 and others 32 , but these observations were not extended to other cell types. The importance of cell type differences in CFSs was recently brought into focus by Le Tallec et al. 33, 34 and Hosseini et al.
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, who studied CFSs in a variety of cell types, including fibroblast, epithelial and erythroid cell lines. Although there were several CFSs found across all cell types, cell type-specific CFSs were also found in most cells, including fibroblasts and epithelial cell lines. For example, FRA3B in FHIT is highly expressed in lymphocytes, lymphoblasts, HCT116 and HeLa cells, but is not expressed in normal fibroblasts, which instead contain a novel CFS at 3q13.3. Other CFSs such as FRA16D in WWOX are expressed in most cell types, although at different frequencies. As described below, recent data have revealed that cell type-specific CFS expression is influenced by the transcription of large genes with implications for genomic rearrangements that have a direct impact on the mutational landscape of cancer cells.
Mechanisms of CFS instability CFS sequences. The agents and growth conditions that induce CFS breaks inhibit replication fork progression, increasing the frequency of stalled and/or collapsed with many loci remaining unreplicated even in G2 (REF. 22) . Subsequent replication timing studies demonstrated that other CFSs experience similar difficulty in either the progression or the completion of replication 19 . Importantly, late replication is not sufficient to fully define a CFS, as other, stable regions of the genome also replicate late in S phase. Nonetheless, it is clear that late-replicating DNA at CFSs is particularly sensitive to replication inhibitors and has a central role in their instability.
CFSs are enriched in large genes. The availability of FISH probes specific for sub-megabase genomic spans allowed for more precise mapping and molecular characterization of breakage across several CFSs, starting with the most frequent CFSs in lymphocytes, FRA3B and FRA16D [23] [24] [25] . These studies revealed that CFS fragility Figure 1 | Possible genomic outcomes of replication stress. DNA replication stress during S phase leads to stalled or collapsed replication forks, which may be resolved in several ways. a | Successful restart and completion of replication leads to an intact, normal genome. b | If regions of unreplicated DNA persist through late S phase, replication may be completed as late as M phase, resulting in an apparent common fragile site (CFS) gap or break due to a lack of normal chromosome condensation. c | If the unreplicated DNA is not resolved and persists to anaphase, ultrafine anaphase bridges can form at these sites. d | If the stalled or collapsed forks are repaired and restarted through an error-prone mechanism, then genome rearrangements, including copy number variants (CNVs), can occur. Alt-EJ, alternative end joining; FHIT, fragile histidine triad; FoSTeS, fork stalling and template switching; MMBIR, microhomology-mediated break-induced replication; POLD3, DNA polymerase δ non-catalytic subunit; SMC2, structural maintenance of chromosomes protein 2. forks genome-wide. But why are CFS loci uniquely sensitive to replication stress? Early studies proposed non-exclusive mechanisms underlying this observation 1, 14, 22, [36] [37] [38] , including the presence of difficult-toreplicate sequences, late replication timing and a paucity of replication origins within CFSs. With the molecular characterization and sequencing of the first CFSs 9, [39] [40] [41] , it was apparent that they are AT-rich and contain long stretches of perfect AT microsatellite sequences that have the potential to form complex secondary structures that could impede replication fork progression. This idea was furthered by the identification of increased numbers of DNA flexibility peaks, defined as areas of high local variation in the twist angle between stacked nucleotide base pairs 42 , suggesting that the formation of abnormal DNA structures could be a causal factor in mediating CFS expression 39, 43, 44 . Indeed, studies in yeast demonstrated that these AT-rich sequences lead to replication arrest and DNA breaks 45 . Questions regarding the necessity and sufficiency of DNA flexibility peaks on CFS instability arose from findings that cells containing FRA3B deletions that removed most DNA flexibility peaks still exhibited CFS breakage 46 and the fact that the human genome contains numerous AT-rich regions of high flexibility that are not CFSs. Thus, AT-rich, flexible DNA is not sufficient to fully define most CFSs, but is likely to contribute to replication failure at these sites. The contributions of sequence composition and non-B-forming DNA secondary structures to CFS instability are important issues that require further elucidation.
Genetic factors.
A deficiency of several factors that are involved in DNA replication and in the replication stress response influences CFS breakage. The first such study found that the ataxia telangiectasia and Rad3-related (ATR) kinase has a major role in maintaining CFS stability by activating a cell cycle checkpoint in response to the incomplete replication at these sites 47 . Cells lacking ATR showed a dramatic increase in CFS expression following APH treatment. Even untreated cells had a low frequency of spontaneous CFS breaks, demonstrating that ATR is required for CFS stability during normal DNA replication. The inhibition of several downstream effectors of ATR, including CHK1, HUS1, Claspin and structural maintenance of chromosomes protein 1 (SMC1; also known as SMC1A), showed similar effects on CFS expression [48] [49] [50] [51] . Other proteins involved in the resolution genomic consequences of incomplete replication and the mechanisms involved in resolving the associated lesions is fundamental to understanding the biological importance of CFS instability in cancers and other disorders. In addition to error-free replication fork restart, there are at least four other major non-exclusive outcomes of incomplete replication at CFSs, each with different genomic and functional consequences, including mitotic replication and fragile site expression, the persistence of unreplicated DNA and anaphase bridge formation, aberrant repair that leads to CNV formation, and DSBs and chromosome rearrangements (FIG. 1) .
M phase replication: CFS gaps and breaks on metaphase chromosomes. It has long been known that CFSs complete replication late in S phase and even later in the presence of replication inhibitors, with unreplicated DNA persisting as late as G2/early M phase 22 . Minocherhomji and colleagues 58 have extended these findings by exploring the events that occur at CFSs during the G2 and M phases of the cell cycle. Remarkably, they found that after APH treatment the passage of incompletely replicated DNA at CFSs into mitotic chromosomes serves as the trigger to activate a novel and distinct M phase replication pathway. This mitotic DNA synthesis requires the SLX4 scaffold protein MUS81-EME endonuclease and the DNA Pol δ non-catalytic subunit POLD3. The requirement of POLD3 suggested that replication could occur by break-induced replication (BIR), which, in yeast, requires the POLD3 orthologue. In addition, Bhowmick et al. 54 and Sotiriou et al. 68 recently showed that RAD52 has a key role in the repair of collapsed replication forks and is essential for CFS replication. Thus, replication at expressed CFSs is not completed until mitotic prophase, suggesting that the cytogenetic manifestation of CFSs results from extremely late replication and a subsequent failure of these regions to undergo normal chromosome condensation. Indeed, these data can explain why CFSs often appear as cytogenetically defined gaps and breaks on metaphase chromosomes, as opposed to acrocentric fragments or translocations that might be expected for chromosome DSBs.
No replication: ultrafine anaphase bridges.
A quite different outcome for CFSs is seen if DNA replication is not completed in M phase. The persistence of a replication intermediate and, probably, unreplicated or the repair of DSBs or of stalled or collapsed replication forks resulting from incomplete replication also affect CFS stability. These proteins include RAD51, RAD52, DNA-dependent protein kinase (DNA-PK), DNA ligase IV, BRCA1, Fanconi anaemia group D2 (FANCD2), the helicases Bloom syndrome protein (BLM) and Werner syndrome ATP-dependent helicase (WRN), the MUS81-EME1 nuclease, as well as the specialized DNA polymerases Pol κ, Pol η, POLD3 and REV3, and the SNM1 homologue B (SNM1B; also known as APOLLO and DCLRE1B) [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] (TABLE 1) ; however, not all of these proteins have been independently confirmed to be involved.
CFSs have a paucity of replication origins.
The importance of replication origin organization and firing in CFS stability is now clear. In an early study of CFS replication origins, Palakodeti et al. 37 used a nascent strand abundance method to identify four putative origins within a 50 kb region of FRA3B and concluded that CFS origins fire less efficiently than control regions upon APH treatment. In a series of elegant DNA combing experiments, Letessier et al. 66 subsequently demonstrated that FRA3B does not show significant differences in replication fork speed or stalling relative to the bulk genome upon APH treatment in lymphoblasts. However, mapping of replication initiation events along FRA3B revealed an initiation-poor region that coincided with the centre of the CFS. This paucity of active replication origins was apparent in lymphoblasts that express FRA3B instability, but not in fibroblasts where FRA3B is not expressed. Conversely, fibroblasts, but not lymphoblasts, showed a paucity of active replication origins within a fibroblastspecific CFS at 3q13.3. These data are consistent with a reduced binding of the origin recognition complex (ORC; which seeds replication origin assembly) within CFSs 67 and suggest a model in which a paucity of replication origins in the centre of CFSs requires converging replication forks from flanking genomic regions to cover long distances in S phase, greatly increasing the risk of incomplete replication under replication stress.
Consequences of CFS instability
It now seems clear that a paucity of active replication origins leads to incomplete DNA replication at CFSs during S phase and is a key factor in initiating CFS instability. Gaining insights into the downstream DNA at CFSs into late mitosis can lead to the formation of ultrafine anaphase bridges (UFBs), which form a 'thread' of DNA that links CFS loci on the separating sister chromatids. UFBs differ from typical anaphase bridges in that they lack histones and cannot be visualized with conventional DNA dyes such as 4ʹ,6-diamidino-2-phenylindole (DAPI). Instead, UFBs are detected by visualizing bound proteins, including PLK1-interacting checkpoint helicase (PICH; also known as ERCC6L), a member of the SWI/SNF2 family of DNA-dependent ATPases, FANCD2, FANCI and BLM [69] [70] [71] , all of which are important for the resolution DNA breaks, genome rearrangements and chromosomal non-disjunction (in which chromosomes do not properly segregate during cell division) 58, 69 . Aberrant repair: CNV formation. A third consequence of unreplicated DNA at CFSs with major biological importance is CNV formation. CNVs are genomic deletions and duplications from tens of base pairs to more than 1 Mb. They occur as normal genomic variants, with tens of thousands described in human populations 72 . Germline CNVs extensively contribute to human genetic and developmental genomic disorders 73, 74 , of UFBs. Although UFBs can be observed in various cell lines after treatment with low-dose APH, their frequency is greatly increased after the depletion of MUS81, SMC2 or other proteins that are involved in M phase DNA synthesis 58 . These findings, coupled with the formation of large p53-binding protein 1 (53BP1; also known as TP53BP1) foci that colocalize with CFSs in the subsequent G1 phase, indicate that CFS-UFBs represent DNA that fails to complete replication during M phase 58 . The fate and biological importance of UFBs are not completely understood, but they are hypothesized to have a role in generating and probably contribute to disease through somatic tissue mosaicism 75, 76 . Importantly, de novo CNVs also arise frequently in cancers 77, 78 , with many containing between tens and hundreds of de novo deletions and duplications.
Durkin et al. 46 provided the first evidence that replication stress and CFS instability can lead to CNVs that are similar to those observed in both normal and tumour cells 46 . They tested the hypothesis that APH treatment of cultured mammalian cells would not only result in CFSs on metaphase chromosomes, but would also give rise to deletions at the CFS FRA3B. Remarkably, up to 23% of treated cells contained deletions that mimicked the FRA3B deletions previously described in cancer cells in both size and breakpoint structure. Using emerging genomic array and sequencing technologies, Arlt and colleagues [79] [80] [81] expanded these findings, and showed that exogenous replication stress, in the form of low-dose APH, hydroxyurea and ionizing radiation, is a potent inducer of CNVs genome-wide in cultured normal human cells [79] [80] [81] , and that some CNVs occurred within CFS-associated genes. These CNV breakpoint junctions primarily had short 2-10 bp microhomologies or blunt ends, which are typical of almost all CNVs that arise in cancers, as well as the majority of CNVs found in normal genomes and de novo, often pathogenic, CNVs that arise through new mutations. These CNVs included complex rearrangements with multiple junctions that probably arose in a single mutational event. Importantly, CNV formation at CFSs does not rely on canonical DSB repair by the non-homologous end joining (NHEJ) pathway, supporting the hypothesis that other DNA replication-associated repair mechanisms have crucial roles in CNV formation 82 . These results support models that involve fork stalling and template switching (FoSTeS), in which nascent DNA strands are proposed to switch replication templates 83 . Microhomology-mediated break-induced replication (MMBIR), a related pathway in which fork cleavage and DSB resection expose the switching DNA strand, and/or alternative end joining probably lead to the genesis of CNVs that arise at CFSs 83 . The relationship between replication timing, experimentally induced CNVs, CFSs and the transcription of large CFS-associated genes was further examined by Wilson et al. 29 . A striking feature of the CNVs was their genomic distribution.
because most long genes have multiple isoforms, and because shorter isoforms are often more prevalent in RNA-seq data, this predictive power is only possible if the complete nascent transcription profile is known. In addition, this type of prediction requires transcription to be assessed in the same cells as those in which CFSs and CNVs are analysed, as highlighted by differences in transcription and CFS and CNV hotspots between two normal human fibroblast cell lines.
These collective findings have led to a model for the instability of CFSs and associated hotspot CNVs that invokes transcription-dependent double-fork failure 29 (FIG. 2) . This model posits that large, late-replicating genes are replicated via forks proceeding inwards from the genomic flanks. Dormant origins within the large transcription units are displaced by the RNA Pol II complex and so are not accessible for activation following replication stress. In this way, large active transcription units organize the locations of fork failures in a manner that is consistent with patterns of CNV formation. The associated nonlinear increase in CNV risk is consistent with mathematical models of the probability of double-fork failure as a function of inter-origin distance 85 . This model infers a paucity of usable origins within large active transcription units that is consistent with observations of reduced firing of late or dormant origins in CFSs that would normally fire under replication stress in other genomic regions 66, 86 , and further involves transcription as a mechanistic feature. Importantly, pre-replication complexes (pre-RCs) are only licensed in G1 phase and must remain bound for firing to occur in S phase. The movement of RNA Pol II through an origin can displace a pre-RC, as demonstrated in yeast 87, 88 . Thus, Wilson et al. 29 suggested that dormant origins fail to rescue transcriptiondependent double-fork failure at CNV hotspots and CFSs because transcription has persisted throughout S phase and has removed pre-RCs before they could be utilized as replication origins. Consistent with the findings of Helmrich et al. 84 , replication fork failure within transcribed genes could be further enhanced by transcription-dependent R-loop formation. Importantly, these transcription-driven phenomena are not likely to be the only mechanisms to lead to a paucity of active replication origins and a high susceptibility to replication stress, but they seem to account for the majority of the most frequent and unstable CFS loci.
Although the majority of CNVs appeared to be random and occurred as isolated events at different genomic locations, a subset of events arose in focal clusters or hotspots, with more than 40% of all CNVs arising in nine hotspots. CFSs were also examined, which revealed that CNV hotspots were all CFSs in these normal human fibroblast cell lines, demonstrating that CFSs and CNVs are different manifestations of replication stress at the same cell type-specific loci. Nascent transcript analysis, conducted with the same cell lines, revealed that all but one of the nine CNV hotspots were within large (>500 kb) genes that were transcribed. Indeed, of the 12 genes that were >1 Mb the long isoforms of which were transcribed in the cells studied, 11 contained CNVs. Conversely, large genes that were not transcribed in these cells did not have CNVs. Importantly, comparing two fibroblast lines with different transcription profiles for specific CFS and CNV hotspot genes demonstrated that locus instability was only found in the cell line that transcribed a long isoform; the expression of a short isoform of the same gene did not correlate with CNV or CFS formation. Finally, replication timing revealed that large CNV and CFS hotspot genes have consistently late replication timing despite being actively transcribed, which was consistent with earlier studies of CFSs 22 . The above studies provide strong evidence that the most frequent and unstable CFSs and CNV hotspots occur at the same loci and that the active transcription of associated large genes is a key factor in their extreme instability. The association with transcription supported the findings of Helmrich et al. 84 who examined the correlation of CFS breaks, transcriptional activity and R-loops at three CFSs in cells with different transcription profiles. They proposed that CFS instability was caused by replication and transcription conflicts that result in R-loop formation and suggested that these conflicts are promoted at CFS genes because they are transcriptionally active in S phase, as the transcription of such large genes requires the entire duration of the cell cycle. Both studies demonstrated that the differential expression of large genes can explain cell type differences in the expression patterns of CFSs. The findings of Wilson et al. 29 further extended this mechanistic relationship to CNVs. An extrapolation of these data is that CFSs and CNV hotspot locations could be predicted in any cell (or tumour) type for which the transcription pattern is known. Importantly, This model can explain the initial events that lead to instability at CFS loci. The downstream consequences depend on the resolution mechanisms that follow. As discussed above, CFSs result from M phase replication and incomplete condensation, and UFBs seem to result from the persistence of unreplicated DNA in anaphase. Exactly when or how CNVs arise remains an important unanswered question. CNVs could form as a result of error-prone repair during the M phase replication steps that create CFSs 58 . Alternatively, CNVs could form through BIR or template switching during late S phase or G2 phase, which would be consistent with the proposed mechanisms of CNV formation 83 . Finally, it is also possible that the unreplicated regions could persist into the next cell cycle, leading larger than 1 Mb, including many known CFS-associated genes. Nearly all (24 of 27) of the RDC-associated genes in NSPCs have neural-specific functions and/or are linked to neurological disorders, including limbic system-associated membrane protein (Lsamp), neurexin 1 (Nrxn1) and deleted in colorectal carcinoma (Dcc). As with the CNVs reported by Wilson et al. 29 , all the genes (except one) were transcribed in the NSPCs studied and were late replicating. The high DSB frequency may result from collapsed replication forks, leading to both CNVs and the translocations that were detected in this assay. Alternatively, DSBs that lead to the detected translocations might represent outcomes distinct from the predominantly intrachromosomal template switching that has been proposed to account to CNV formation by erroneous repair, probably in G1 phase. Understanding the timing of CNV formation at CFS loci will be an important step in predicting and experimentally interrogating the repair mechanisms involved.
DSBs and chromosome rearrangements.
Wei et al. 89 recently provided novel insights into the occurrence of DSBs at CFSs. Using a targeted sequencing assay to detect DSB-mediated translocations and other rearrangements, they characterized thousands of DSBs across the genome and identified 27 recurrent DSB clusters (RDCs) in mouse neural stem and progenitor cells (NSPCs). In total, 26 of 27 RDCs mapped within genes larger than 400 kb, with 50% mapping in genes Nature Reviews | Cancer Replication fork failures resulting from replication stress that occur at most genomic loci, including non-transcribed large genes, can be rescued by the firing of late, or 'dormant', origins within the unreplicated region, leading to complete replication (left-hand side). Large genes in which transcription persists into S phase are at a high risk of incomplete replication, leading to copy number variants (CNVs), common fragile sites (CFSs) and ultrafine anaphase bridges (UFBs; right-hand side). The transcription-dependent double-fork failure (TrDoFF) model of extreme locus instability under replication stress 29 proposes that this is a result of the simultaneous failure of two converging forks, for example, through the formation of R-loops, and that this creates large, late-replicating domains where the displacement of pre-replication complexes (pre-RCs) by prolonged transcription into S phase prevents dormant origin firing. CFS breaks and deletion CNVs arise within the resulting unreplicated DNA region and duplications arise on the flanks (red arrows) probably due to fork stalling and template switching (FoSTeS), microhomologymediated break-induced replication (MMBIR) or alternative end joining (Alt-EJ). Pol II, RNA polymerase II. Modified from Wilson et al.
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for CNV formation. Understanding the disposition of transcription-dependent replicative lesions through different repair pathways and their coordination in the cell cycle are important challenges. The fact that many of the largest mammalian genes have neuronal functions supports the potential for brain-specific genomic rearrangements affecting these genes. The potential biological importance of DSBs in these genes is underscored by the fact that NHEJ-mutant mice show impaired neuronal development, a motivating factor for Wei et al. 89 . The studies described above and those of Wei et al. 89 support a role for transcription in this process. It has long been known that the most frequently observed CFSs lie in large genes, many of which are involved in neuronal development and function, and this relationship can now be better explained. It is unknown why many of the same genes, such as LSAMP and AUTS2, are also transcribed in human fibroblasts and, presumably, in some cancer cells, where they are CNV hotspots.
Cancer and genomic disorders Viral integration sites. Some viral integration sites have been known to be contained within certain CFSs since early sequencing studies of a segment of the FRA3B locus revealed a previously identified human papilloma virus 16 (HPV-16) integration site in a primary cervical carcinoma 90 . Subsequent observations reported viral integrations at numerous CFSs in tumours and tumour cell lines [91] [92] [93] [94] [95] [96] . Recent work with papillomaviruses demonstrated an association of viral E2 protein with chromatin at CFSs. This study suggested that HPV replication, which utilizes host DNA damage response proteins, occurs near regions of the genome that are prone to DNA damage (that is, CFSs) 97 . In addition, Hu et al. 98 found that HPV integration site junctions had short microhomology signatures between the host and the viral genomes, similar to those found at CNV breakpoints. On the basis of these data, Hu et al. 98 proposed a model for viral integration in which HPV drives integration into the host genome by hijacking the FoSTeS and MMBIR repair pathways believed to be involved in CNV formation, raising the intriguing possibility that viral integration, chromosome fragility and CNV formation could be driven by the same molecular processes during replication stress.
Other studies failed to observe associations between viral integration and CFSs. Although a recent meta-analysis correspond to known cancer genes 10 . Among the 70 deletion regions, 22 regions localized to a subset of the 100 largest human genes, including FHIT, WWOX and other CFS-associated genes.
Our examination of the most recent TCGA data, encompassing 10,221 tumour specimens, revealed that many, if not all, of the CFSs and CNV hotspots described by Wilson et al. 29 corresponded to similar cancer focal deletions in one or more tumour types (FIG. 3) . Of the 28 strongest focal deletions in cancer, 19 were at genes >500 kb in size, 9 of which were listed in the Tumor Suppressor Gene Database (TSGene) 2.0 (REF. 109) ; the remaining 9 all included smaller tumour suppressor genes. Several of the large genes are known CFSs, including WWOX, FHIT, PARK2 (also known as PRKN), inner mitochondrial membrane peptidase subunit 2 (IMMP2L) and LSAMP, and all are predicted to be CFSs and CNV hotspots in the cells in which they are expressed 29 . A higher resolution comparison of cancer focal deletions to CNVs experimentally induced by APH, hydroxyurea and low-dose ionizing radiation revealed a strikingly similar and highly specific pattern within these large genes (FIG. 4) . For example, both experimental and cancer deletions in LSAMP cluster around the centre of the gene, with remarkably similar CNV sizes and breakpoint locations, as found in uterine corpus endometrial carcinomas (UCECs) and ovarian serous cystadenocarcinomas (FIG. 4a) . The same pattern is even more strongly evident in an aggregate analysis of all genes larger than 1 Mb (FIG. 4b) , strongly suggesting that CNVs are formed by the same mechanisms in both cell models and cancer. The consistent central location of large gene deletions is readily predicted by the replication-and transcription-dependent model described above (FIG. 2) and suggests that this mechanism drives many large gene deletions, as less frequently observed terminal deletions would also disable gene function. Importantly, different tumour types have different focal deletion signatures. For example, the unstable experimentally induced CNV hotspot and CFS in fibroblasts within LSAMP is a strong focal deletion in ovarian serous cystadenocarcinoma and adrenocortical carcinoma, but is not a focal deletion in many other tumour types (FIGS 3, 4c) . Other large genes have very different patterns, such as CSMD1, which is a focal deletion in 6 of the 21 tumour types (FIG. 4c) . The of HPV, hepatitis B virus (HBV) and Merkel cell polyomavirus (MCPyV) found integrations within CFSs in cervical and other carcinomas, these integrations were not at a higher frequency in CFSs than elsewhere in the genome 99 . It is noteworthy that integration hotspots have been described in large genes that were not previously described as CFSs, such as LDL receptor related protein 1B (LRP1B; 1.9 Mb), CUB and Sushi multiple domains 1 (CSMD1; 2.1 Mb) and discs large MAGUK scaffold protein 2 (DLG2; 2.2 Mb) 91, 92, 98 , but that are predicted to be fragile sites in the cells in which they are transcribed 29 .
A similar meta-analysis of viral integration site associations with large genes and transcription, which is highly dysregulated in cancer, could further inform the extent of integration at cell type-specific fragile sites.
Focal deletions at CFSs in cancer.
The transcription of large genes in dividing cells leads to an increased risk of instability by creating a high probability of double fork failures, in which two converging replication forks do not replicate the DNA between them, while simultaneously preventing the proper resolution of these unstable structures 29 . This model predicts that large genes will be CNV hotspots in the replicating cell types in which long isoforms are transcribed and has major implications for understanding CNV formation during tumorigenesis. Numerous reports have described frequent hemizygous or homozygous deletions of tens to hundreds of kilobases in CFS regions in cancer cell lines and primary tumours. Most studies have focused on FRA3B and FRA16D, which map within the large FHIT and WWOX genes, respectively 8, 100 ; however, similar deletion patterns were also shown for other CFSs, including FRA6E 101 , FRA9E 102 and FRA7G 103 . These deletions can occur early, and deletions in FHIT and other CFS genes are found in precancerous lesions, including those in the colon, bladder and Barrett oesophagus in association with activated DNA damage checkpoints [104] [105] [106] [107] . At least four recent studies have catalogued acquired CNVs in large cohorts of human tumours and have concluded that many genomic loci repeatedly show focal deletions and amplifications in a cancer-specific manner, with many of the prevalent focal deletions targeting CFSs and large genes 10, 77, 78, 108 . For example, a study of CNVs in 4,934 TCGA cancer samples found repeated focal CNVs in 140 regions (70 losses and 70 gains), 102 of which did not presence of cancer CNVs within large genes in only a subset of cancer types is consistent with the model that only cancers (or their precursor cells) that actively transcribe a long isoform of a large gene will have a high risk of CNVs at that locus. By contrast, cyclin-dependent kinase inhibitor 2A (CDKN2A) is a clear focal deletion hotspot in almost all cancer types despite not corresponding to a large gene, as it is an important tumour suppressor gene that drives tumour formation 110 . replication stress is a key component of the early tumorigenic process and that it can be induced by oncogene overexpression in vivo 111, 112 . Activated oncogenes are a key feature of early cancer development, with a major outcome being the induction of genome instability and DNA damage, including at CFSs [112] [113] [114] . Oncogene activation can deregulate replication in a number of ways, including by decreasing the number of licensed origins leading to under-replicated Oncogene stress. The accumulation of CNVs in large CFS-associated genes in cancers suggests that the CNVs that are induced in cultured cells effectively mimic the processes that occur in vivo, and that cancer cell CNVs also occur in response to replication stress. In cultured cells, APH and other inhibitors of DNA replication are used to induce replication stress, leading to CFSs and associated CNVs, but what creates this replication stress in cancer cells in vivo? Several studies have indicated that Nature Reviews | Cancer T  T  T  T   T   T   T   T   T  T   TL  TL  TL TL  TL  TL  TL TL   TL  TL   TL   TL  TL   TL  TL   TL  TL   TL   TL   TL TL  TL DNA, through unscheduled replication initiation leading to re-replication, by direct effects on replication fork progression and by leading to the accumulation of damaging reactive oxygen species 115 . The manner, which is interpreted as evidence for increased topological stress during replication. These observations led to a model of nucleolytic processing of unusual replication intermediates during mitosis overexpression of cyclin E and cell division cycle 25A (CDC25A) slows replication forks and induces fork reversal, which activates the DNA damage response during G2/M phase in a MUS81-dependent 29 (blue) and a large proportion of cancer (red) deletion CNVs specifically and precisely accumulate at the centres of these large genes in a manner that is consistent with the model in FIG. 2 . c | Examples of deletion CNV hotspot specificity by tumour type. Differences between ovarian serous cystadenocarcinoma (blue) and head and neck squamous carcinoma (red) are shown with respect to acquired deletion CNV occurrence in genes LSAMP and CUB and Sushi multiple domains 1 (CSMD1). Data summarized in this figure were generated in part by the TCGA and obtained from FireBrowse 142 . ZBTB20, zinc finger and BTB domain containing 20. 
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Chr8 coordinate (Mb) 117 . Interestingly, oncogene stimulation of transcription and associated R-loop formation, in which RNA hybridizes to a complementary DNA strand, forming an RNA-DNA hybrid with the displacement of the other DNA strand, is one important mechanism by which these replication outcomes arise, further supporting a link between transcription, replication and genomic instability in cancer 118 . Consistent with these observations, genomic instability preferentially occurs at CFSs following experimentally induced, aberrant oncogene expression 113, 119 . Recent studies have demonstrated that the overexpression of cyclin E or of HRAS-G12V in normal human fibroblasts leads to chromosomal breakage, with each oncogene creating a unique fragility landscape that overlaps APH-induced CFSs, as well as a number of unique sites 120 . Oncogene-induced fragile sites share features with APH-induced CFSs, including colocalization with large genes and recurrent instability hotspots in cancer. This overlap between oncogene-induced fragile sites and large genes further supports the model that most large genes are in fact fragile sites under specific replication stress conditions 28, 29 . If any CFS or CNV hotspots harbour tumour suppressor genes, genome instability that is driven by the overexpression of oncogenes could potentially preferentially inactivate these genes and could drive the cell further down the tumorigenic pathway.
Functional role of CFS-associated genes in cancer. The observation that CFS-associated genes are frequently deleted in cancers raises the important question of what functions these deletions might have in tumorigenesis. FHIT, WWOX and several other CFS-associated genes have been proposed to be tumour suppressor genes, and their loss may lead to cancer development 121, 122 . This hypothesis has been supported by studies indicating that the deletion and/or the reduced expression of these genes is a predictor of poor outcome in many different cancers. The largest body of data is on FHIT, with numerous reports of genomic alterations and the loss of protein expression in preneoplasias, suggesting a tumour-suppressive role suppressor genes. Given the instability of CFS-associated genes and their high risk of CNV formation at these loci, focal intragenic deletions in CFS-associated genes are not sufficient evidence of tumour suppressor function. However, high inherent instability and functional importance are not necessarily mutually exclusive. CFS-associated genes with different functional properties should not be considered together when investigating their possible roles in cancer. Clearly, additional functional studies, which are verified in independent laboratories, are required to reach firm conclusions about a mechanistic role of specific CFS-associated genes in tumorigenesis.
CFS genes in genomic disorders. Finally, the potential important biological implications of instability of CFS-associated genes extend beyond cancer. Many of these genes have important roles in neurodevelopment and many CFS-associated CNV hotspots in cultured cells correspond to a subclass of clinically relevant human CNVs implicated in developmental disorders 27, 29 . For example, constitutional deletions within AUTS2, IMMP2L and NRXN1 have been associated with autism spectrum disorder, intellectual disability and psychiatric disorders [137] [138] [139] . Other large genes, such as CNTNAP2, in which intragenic CNVs are found in several neurodevelopmental disorders 140 were not expressed in the cell types used by Wilson et al. 29 , but are predicted to be CFSs and CNV hotspots in the replicating cell types in which they are expressed, which could include neural progenitor cells, germ cell precursors and early post-zygotic cells. Emerging approaches for single-cell genomics should soon allow tests of this prediction.
Conclusions and perspectives CFS gaps and breaks on metaphase chromosomes were discovered more than 35 years ago as the first indicators of the unusually high instability of large, late-replicating genes that also manifests as frequent and, in many cases, unexplained focal CNVs in cancer. We now know that the most frequent and unstable CFSs are enriched within large genes with a paucity of replication origins and that active transcription greatly increases their instability, leading to late or incomplete replication under conditions of replication stress. These perturbations of DNA replication can lead to several different outcomes depending on the resolution of these unreplicated regions including, beginning in the early stages of cancer development 106, 123, 124 . The loss of FHIT expression via promoter methylation and/or deletion has been associated with tumour progression and reduced survival in a number of cancer types 125, 126 . Homozygous and hemizygous deletions that affect the WWOX locus have been reported in several types of cancer 122, 127 and similar but less extensive data are available for some other CFS-associated genes 128 . Most functional studies on CFS genes have also focused on FHIT, WWOX and, more recently, PARK2, linking them to the DNA damage response in cultured cells and mouse cancer models 121 . Loss of FHIT has been reported to result in dNTP imbalance and spontaneous replication stress 129 , and WWOX has been reported to function in the activation of the ATR-mediated DNA damage checkpoint response activation 130 . Consistent with these hypotheses, both Fhit-and Wwox-deficient mice exhibit increased cancer incidence and susceptibility to carcinogen-induced cancers [131] [132] [133] . The ectopic expression of WWOX in WWOX-deficient cancer cells suppresses cell and tumour growth in immune-compromised mice and the ablation of WWOX in mice resulted in a higher incidence of lesions that resembled osteosarcomas and lung and mammary tumours 134 . The mechanisms by which FHIT, a dinucleoside triphosphatase, and WWOX, an oxidoreductase, might function in the DNA damage response are not entirely clear. A better understood mechanistic path to genome instability has been reported by Gong et al. 135 , who showed that the PARK2 E3 ubiquitin ligase co-ordinately controls the stability of both cyclin D and cyclin E. The inactivation of PARK2 results in the accumulation of cyclin D and the acceleration of cell cycle progression. Thus, the PARK2 CFS regulates cyclin-CDK complexes, as does the CDK inhibitor p16 (which is encoded by CDKN2A), and acts as a major regulator of the stability of G1/S cyclins, which are crucial factors in genome stability.
Others have argued that CFS-associated gene deletions in cancer cells are simply passenger mutations that result from the inherent instability of the CFSs 78, 136 . This view is supported by the predominance of hemizygous versus homozygous deletions, the paucity of inactivating point mutations in the genes in tumours, and the frequent failure of deletions to affect the RNA or protein expression of associated genes 108 , all of which are common features of tumour most importantly for cancer and perhaps normal somatic tissues, CNV formation. In cancer, this relationship is particularly exacerbated because the early stages of oncogenic transformation represent a form of transcription-associated replication stress that can potentiate further genomic instability and CNV formation. Data from our laboratory have shown that CFSs and CNV hotspots are different manifestations of the same mechanistic process that is driven by large, active transcription units. The transcription of large genes in dividing cells is an important factor in the mechanisms that lead to CFSs and associated CNV hotspots, setting up a 'perfect storm' of instability that is driven by replication stress and double-fork failure. These data predict that large genes will be CFSs and CNV hotspots in the replicating cell types in which their long isoforms are expressed, enabling the identification of potential CFS and CNV hotspots from any cells or tissue in which the nascent transcription profile is known. They also suggest that the transcriptional differences among individual tumours or the cells from which they arose probably explain differences in CNV hotpots that are observed in different cancers. It is important to note that not all genomic regions with a paucity of replication origins reside within large transcribed genes, and further attention should be also given to transcription-independent mechanisms of origin suppression and other mechanisms that lead to incomplete replication that may function in less frequent CFSs and CNVs. Finally, the opposing views of whether CFS genes such as FHIT, WWOX and PARK2 are important in cancer progression or are simply passengers with frequent deletions that result from CFS hypermutability will only be resolved with continued rigorous and independently verified gene-specific functional studies.
